Opportunity Information: Apply for PAR 19 268
The National Institutes of Health (NIH) funding opportunity titled "Conference for Early Stage HIV/AIDS Researchers Using Nonhuman Primate Models (R13 Clinical Trial Not Allowed)" (Funding Opportunity Number PAR-19-268) supports the planning and delivery of an annual, intensive workshop or conference aimed specifically at early stage HIV/AIDS investigators who use nonhuman primate (NHP) models. The central purpose is to help these researchers strengthen the bridge between preclinical NHP findings and eventual human clinical trials by giving them practical, field-specific guidance on designing, interpreting, and presenting NHP studies in ways that meaningfully inform clinical development decisions.
The meeting is expected to focus on how NHP research can reduce the incidence of HIV infection and advance HIV/AIDS interventions. Priority scientific themes include HIV vaccine development and testing, the development of next-generation HIV therapies (including strategies that may contribute to cure research), and research addressing HIV-associated coinfections, comorbidities, and complications. The agenda should also cover infection prevention strategies and the broader translational pathway from animal-model results to human trial concepts, including what kinds of evidence are most persuasive and actionable when moving toward clinical evaluation.
Beyond scientific content, the FOA places strong emphasis on professional development for early stage researchers. Applicants are encouraged to design a conference that builds real-world skills in networking and collaboration, grantsmanship (such as crafting competitive NIH applications and understanding review expectations), and developing goal- and milestone-driven research plans. In other words, the event is meant to function not only as a technical training venue, but also as a career-building and community-forming platform that helps newer investigators establish sustainable, fundable research trajectories in HIV/NHP translational science.
The FOA also highlights specific methodological and contextual issues that should be addressed in conference programming. These include statistical considerations relevant to NHP research designs and inference, host genetics factors that may affect outcomes and translation, and practical methods for translating NHP findings into clinical trial strategies in humans. Another expected topic area is how to create or refine NHP research programs so that they better mirror clinical observations in people living with HIV, strengthening the relevance of animal model work to real patient populations and clinical endpoints.
This opportunity uses the NIH Research Conference Grant mechanism (R13) and is categorized under Health (CFDA 93.351). It is explicitly "Clinical Trial Not Allowed," meaning the award is intended to support the conference activity rather than the conduct of clinical trials. The original closing date listed for this announcement was 2019-09-10, and the posting creation date was 2019-05-03.
Eligibility is broad across U.S.-based organizations and includes state, county, and local governments; public and private institutions of higher education; nonprofit organizations (with or without 501(c)(3) status); for-profit organizations (other than small businesses) and small businesses; independent school districts; public housing authorities/Indian housing authorities; and federally recognized Native American tribal governments, as well as tribal organizations that are not federally recognized. The FOA also calls out additional eligible applicant types such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Tribally Controlled Colleges and Universities (TCCUs), eligible federal agencies, faith-based or community-based organizations, regional organizations, and U.S. territories or possessions.
At the same time, the announcement is clear about restrictions related to foreign involvement. Non-domestic (non-U.S.) entities and foreign institutions are not eligible to apply, and non-domestic components of U.S. organizations are not eligible. Foreign components, as defined by the NIH Grants Policy Statement, are not allowed. In practice, this means the conference project must be organized and carried out within the allowable U.S.-based institutional framework without foreign components under NIH definitions.Apply for PAR 19 268
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Conference for Early Stage HIV/AIDS Researchers Using Nonhuman Primate Models (R13 Clinical Trial Not Allowed)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.351.
- This funding opportunity was created on 2019-05-03.
- Applicants must submit their applications by 2019-09-10. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
FAQs: NIH R13 Conference for Early Stage HIV/AIDS Researchers Using Nonhuman Primate Models (PAR-19-268)
What is this funding opportunity?
This is an NIH Research Conference Grant (R13) funding opportunity titled "Conference for Early Stage HIV/AIDS Researchers Using Nonhuman Primate Models (R13 Clinical Trial Not Allowed)" under Funding Opportunity Number PAR-19-268. It supports the planning and delivery of an annual, intensive workshop or conference.
What is the main purpose of the conference this grant supports?
The central purpose is to support an intensive meeting designed for early stage HIV/AIDS investigators who use nonhuman primate (NHP) models, with an emphasis on strengthening the bridge between preclinical NHP findings and eventual human clinical trials. The conference is expected to provide practical, field-specific guidance on designing, interpreting, and presenting NHP studies in ways that inform clinical development decisions.
Who is the conference intended to serve?
The meeting is aimed specifically at early stage HIV/AIDS researchers who use NHP models. In addition to scientific training, it is meant to function as a professional development and community-building platform for newer investigators.
What scientific areas should the conference emphasize?
The conference is expected to focus on how NHP research can reduce the incidence of HIV infection and advance HIV/AIDS interventions. Priority scientific themes include:
- HIV vaccine development and testing
- Development of next-generation HIV therapies, including strategies that may contribute to cure research
- Research addressing HIV-associated coinfections, comorbidities, and complications
Does the agenda need to address prevention and translation to human trials?
Yes. The agenda is expected to cover infection prevention strategies and the broader translational pathway from animal-model results to human trial concepts. It should address what types of evidence from NHP studies are most persuasive and actionable when moving toward clinical evaluation.
What career and professional development topics are encouraged?
The FOA strongly emphasizes professional development for early stage researchers. Applicants are encouraged to include programming that helps attendees build real-world skills in:
- Networking and collaboration
- Grantsmanship (for example, crafting competitive NIH applications and understanding review expectations)
- Developing goal- and milestone-driven research plans
What methodological issues should be addressed in the conference programming?
The FOA highlights several methodological and contextual issues that are expected to be addressed, including:
- Statistical considerations relevant to NHP research designs and inference
- Host genetics factors that may affect outcomes and translation
- Practical methods for translating NHP findings into clinical trial strategies in humans
Is the conference expected to address how NHP research mirrors clinical observations in people?
Yes. Another expected topic area is how to create or refine NHP research programs so they better mirror clinical observations in people living with HIV, strengthening the relevance of animal model work to real patient populations and clinical endpoints.
What grant mechanism is used for this opportunity?
This opportunity uses the NIH Research Conference Grant mechanism (R13).
What does "Clinical Trial Not Allowed" mean in this FOA?
"Clinical Trial Not Allowed" means the award is intended to support conference activities (planning and delivery of the meeting) rather than the conduct of clinical trials.
What is the CFDA number and category for this opportunity?
The opportunity is categorized under Health and is listed as CFDA 93.351.
What is the funding opportunity number?
The funding opportunity number is PAR-19-268.
When was this opportunity created and what was the original closing date?
The posting creation date listed is 2019-05-03, and the original closing date listed for the announcement was 2019-09-10.
Which U.S.-based organizations are eligible to apply?
Eligibility is broad across U.S.-based organizations and includes:
- State, county, and local governments
- Public and private institutions of higher education
- Nonprofit organizations (with or without 501(c)(3) status)
- For-profit organizations (other than small businesses) and small businesses
- Independent school districts
- Public housing authorities/Indian housing authorities
- Federally recognized Native American tribal governments
- Tribal organizations that are not federally recognized
- U.S. territories or possessions
Are certain institution types specifically called out as eligible?
Yes. The FOA explicitly calls out additional eligible applicant types, including:
- Historically Black Colleges and Universities (HBCUs)
- Hispanic-serving Institutions
- Alaska Native and Native Hawaiian Serving Institutions
- Asian American Native American Pacific Islander Serving Institutions (AANAPISIs)
- Tribally Controlled Colleges and Universities (TCCUs)
- Eligible federal agencies
- Faith-based or community-based organizations
- Regional organizations
Are non-U.S. (foreign) institutions eligible to apply?
No. Non-domestic (non-U.S.) entities and foreign institutions are not eligible to apply.
Can a U.S. organization include a non-domestic component in the project?
No. Non-domestic components of U.S. organizations are not eligible.
Are foreign components allowed under NIH definitions?
No. Foreign components, as defined by the NIH Grants Policy Statement, are not allowed. In practice, the conference project must be organized and carried out within the allowable U.S.-based institutional framework without foreign components under NIH definitions.
Is this award intended to fund research studies in nonhuman primates?
The FOA describes support for planning and delivering an annual, intensive workshop or conference. The focus is on training, guidance, and translation of NHP findings toward clinical development decisions, rather than funding the conduct of research studies through this mechanism.
What is the expected format or intensity of the meeting?
The FOA describes the meeting as an annual, intensive workshop or conference, indicating a concentrated program designed to provide practical guidance and professional development for early stage investigators.
What kind of translational outcomes is the conference trying to strengthen?
The intended outcome is stronger alignment between preclinical NHP evidence and eventual human clinical trial concepts, including clearer guidance on study design, interpretation, and presentation so that NHP results meaningfully inform clinical development decisions.
Browse more opportunities from the same category: Health
Next opportunity: Technologies to Advance Precision Medicine Diagnosis and Treatment of Infertility, Reproductive Tract and Gynecologic Disorders Affecting Fertility (R43/R44 Clinical Trial Optional)
Previous opportunity: Innovative Approaches for Improving Environmental Health Literacy (R43/R44 Clinical Trial Not Allowed)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 19 268
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 19 268) also looked into and applied for these:
| Funding Opportunity |
|---|
| Medicare Model Guidelines, Version 8 Apply for CMS 1C0 19 001 Funding Number: CMS 1C0 19 001 Agency: Centers for Medicare Medicaid Services Category: Health Funding Amount: $100,000 |
| HIV/AIDS Scholars Using Nonhuman Primate (NHP) Models Program (K01 Independent Clinical Trial Not Allowed) Apply for PAR 19 267 Funding Number: PAR 19 267 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Lucidity in Dementia (R21/R33 Clinical Trial Optional) Apply for RFA AG 20 017 Funding Number: RFA AG 20 017 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Lucidity in Dementia (R21 Clinical Trial Optional) Apply for RFA AG 20 016 Funding Number: RFA AG 20 016 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Cognitive Systems Analysis of Alzheimer's Disease Genetic and Phenotypic Data (U01 Clinical Trial Not Allowed) Apply for PAR 19 269 Funding Number: PAR 19 269 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| The NIGMS Human Genetic Cell Repository (U42 - Clinical Trial Not Allowed) Apply for RFA GM 19 002 Funding Number: RFA GM 19 002 Agency: National Institutes of Health Category: Health Funding Amount: $2,000,000 |
| Summer Research Training in Aging for Medical Students (T35 Clinical Trial Not Allowed) Apply for RFA AG 20 008 Funding Number: RFA AG 20 008 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Pragmatic Trials of Managing Multimorbidity in Alzheimer's Disease (R61/R33 Clinical Trial Required) Apply for RFA AG 20 029 Funding Number: RFA AG 20 029 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Centers Without Walls for Collaborative Research in the Epilepsies: Functional Evaluation of Human Genetic Variants (U54 Clinical Trial Not Allowed) Apply for RFA NS 19 019 Funding Number: RFA NS 19 019 Agency: National Institutes of Health Category: Health Funding Amount: $1,500,000 |
| Private Sector Partnership Addressing Emerging Zoonoses and Antimicrobial Resistance Apply for GH BAA 2018 ADDENDUM02 Funding Number: GH BAA 2018 ADDENDUM02 Agency: Agency for International Development Category: Health Funding Amount: $40,000,000 |
| NIAID Clinical Trial Planning Grant (R34 Clinical Trial Not Allowed) Apply for PAR 19 281 Funding Number: PAR 19 281 Agency: National Institutes of Health Category: Health Funding Amount: $150,000 |
| Sponsored Programs Administration Development (SPAD) Program (UC2 - Clinical Trial Not Allowed) Apply for RFA RM 19 004 Funding Number: RFA RM 19 004 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Innovations in Malaria Vaccine Development (IMV) Apply for GH BAA 2018 ADDENDUM03 Funding Number: GH BAA 2018 ADDENDUM03 Agency: Agency for International Development Category: Health Funding Amount: $35,500,000 |
| Postdoctoral Research Associate Training (PRAT) Program (Fi2) Apply for PAR 19 286 Funding Number: PAR 19 286 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Drug Screening with Biofabricated 3-D Skin Disease Tissue Models (U18 Clinical Trial Not Allowed) Apply for RFA TR 19 020 Funding Number: RFA TR 19 020 Agency: National Institutes of Health Category: Health Funding Amount: $400,000 |
| The Electronic Medical Records and Genomics (eMERGE): Genomic Risk Assessment and Management Network - Enhanced Diversity Clinical Sites (U01 Clinical Trial Required) Apply for RFA HG 19 014 Funding Number: RFA HG 19 014 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Cooperative Agreement to Support Navigators in Federally-facilitated Exchanges Apply for CA NAV 19 001 Funding Number: CA NAV 19 001 Agency: CMS-Consumer Information Insurance Oversight Category: Health Funding Amount: Case Dependent |
| The Electronic Medical Records and Genomics (eMERGE): Genomic Risk Assessment and Management Network - Coordinating Center (U01 Clinical Trial Required) Apply for RFA HG 19 015 Funding Number: RFA HG 19 015 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limited Competition: NIA Genome Center for Alzheimer's Disease (U54 Clinical Trial Not Allowed) Apply for PAR 19 288 Funding Number: PAR 19 288 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Understanding Senescence in Brain Aging and Alzheimer's Disease (R01 Clinical Trial Not Allowed) Apply for RFA AG 20 025 Funding Number: RFA AG 20 025 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 19 268", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.